The two fAD iPSCs carry APP gene duplication mutation (APP2) and APPV717I single-site mutation (HVRD), respectively, which are positively associated with AD pathology caused by increased Aβ due to higher APP level or increased processing (Israel et al., 2012; Muratore et al., 2014). The gene discussed is APP; the disease is Alzheimer disease.